---
title: "Avricore Health’s HealthTab signs multi-year collaboration with Abbott for UK point-of-care testing distribution"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296474749.md"
description: "Avricore Health’s HealthTab unit has signed a multi-year collaboration with Abbott to distribute point-of-care testing services across the UK. Under the agreement, HealthTab will supply Abbott’s Afinion 2 Analyzer to NHS-linked pharmacies for HbA1c and lipid-profile screening. The deal leverages HealthTab’s cloud platform to integrate analyzers and workflows, while HealthTab manages quality assurance through CEQAL standards."
datetime: "2026-08-20T10:30:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296474749.md)
  - [en](https://longbridge.com/en/news/296474749.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296474749.md)
generator: "portal-rs"
---

# Avricore Health’s HealthTab signs multi-year collaboration with Abbott for UK point-of-care testing distribution

-   Avricore Health’s HealthTab unit signed a multi-year collaboration agreement with Abbott for point-of-care testing distribution across the UK. \* HealthTab will supply Abbott’s Afinion 2 Analyzer to NHS-linked pharmacies for HbA1c testing and lipid-profile screening. \* Deal sets a framework to expand community-pharmacy testing, using HealthTab’s cloud platform to integrate analyzers, results, and workflows. \* HealthTab will run quality management via CEQAL, including centralized reagent lot monitoring, internal controls, and external quality-assessment events. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avricore Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608200630PRIMZONEFULLFEED9813355) on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [Murphy Pohlad Asset Management LLC Purchases 12,140 Shares of Abbott Laboratories $ABT](https://longbridge.com/en/news/296461096.md)
- [Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative?](https://longbridge.com/en/news/296546525.md)
- [Abbott settles appeal over $495 million infant formula verdict](https://longbridge.com/en/news/296386129.md)
- [Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants | ABT Stock News](https://longbridge.com/en/news/296532468.md)
- [Abbott agrees to $670 million settlement of infant formula cases](https://longbridge.com/en/news/296534956.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**